Journal of Pediatric and Adolescent Gynecology
Volume 19, Issue 5 , Pages 321-323 , October 2006

NASPAG, the “Go To” Society

References 

  1. Giles M, Garland S. Human papillomavirus infection: An old disease, a new vaccine. Aust NZ J Obstet Gynaecol. 2006;46:180
  2. Linhares A, Villa L. Vaccines against rotavirus and human papillomavirus (HPV). J Pediatr. 2006;82(suppl):1
  3. Weinstock H, Berman S, Cates W. Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000. Perspect Sex Reprod Health. 2004;36:6
  4. Wiley D, Masongsong E. Human papillomavirus: the burden of infection. Obstet Gynecol Surv. 2006;61(6 suppl):S3
  5. Stanley M. Human papillomavirus vaccines. Rev Med Virol. 2006;16:139
  6. Harper D, Franco E, Wheeler C, et al. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomized control trial. Lancet. 2006;367:1247

PII: S1083-3188(06)00223-3

doi: 10.1016/j.jpag.2006.07.002

Journal of Pediatric and Adolescent Gynecology
Volume 19, Issue 5 , Pages 321-323 , October 2006

Article Tools

* Image Usage & Resolution